Norstella

Norstella is a global leader in pharmaceutical intelligence, dedicated to accelerating patient access to life-saving therapies. The company unites several prominent organizations—Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group—to offer a comprehensive suite of solutions that span the entire drug development lifecycle, from pipeline to patient.

In November 2022, Norstella completed its merger with Citeline, formerly known as Pharma Intelligence, forming a $5 billion global entity. This strategic consolidation expanded Norstella's capabilities, enabling it to provide end-to-end solutions that guide life sciences companies through the complexities of drug development.

This facilitates quicker patient access to therapies, significantly enhancing the pace of innovation in the healthcare industry.

Innovative Data Solutions

A cornerstone of Norstella's offerings is NorstellaLinQ, introduced in October 2024. This innovative data asset integrates over 74 billion connected data points, combining real-world data—including open and closed claims, lab results, and electronic medical records—with proprietary forecasting, clinical, regulatory, payer, coverage, and commercial intelligence.

By unifying these diverse data sources, NorstellaLinQ empowers clients to make informed decisions, accelerate drug development, and enhance commercialization strategies.

Mission and Impact

Norstella's mission is to simplify the path to innovative, life-saving therapies for patients and providers. By integrating real-world data, predictive analytics, and patient-centric models, the company improves the success rates of clinical trials, identifies patients and coverage paths, and fosters a more effective and economically sound health system.

This approach ensures that therapies reach the people who need them sooner, transforming the industry and having a positive impact on lives worldwide.

Company Size and Team

Norstella boasts a diverse team of over 1,600 employees who collaborate to deliver comprehensive solutions that address the challenges of the pharmaceutical industry. Their expertise spans from early clinical development through to commercialization.

Location

• Bismarck, ND, USA (Headquarters)

With a global presence, Norstella operates across multiple locations, centering its headquarters in Bismarck, North Dakota.

Summary

In summary, Norstella stands at the forefront of pharmaceutical intelligence, offering integrated solutions that streamline the drug development process and enhance patient access to essential therapies.

Through its innovative data assets and strategic partnerships, Norstella continues to drive advancements in the healthcare sector, ensuring that life-saving treatments reach those in need more efficiently.